Veterinary Pharmacovigilance Market Size, Share, Trends, Industry Analysis Report: By Solution (Software and Services), Type, Product, Animal Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast
Description
The global veterinary pharmacovigilance market size is expected to reach USD 3,257.51 million by 2034, according to a new study by Polaris Market Research. The report “Veterinary Pharmacovigilance Market Size, Share, Trends, Industry Analysis Report: By Solution (Software and Services), Type, Product, Animal Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Veterinary pharmacovigilance refers to the systematic process of monitoring, detecting, assessing, and preventing adverse effects and other safety concerns related to veterinary medicinal products. It ensures the safe and effective use of veterinary drugs by identifying potential risks, adverse drug reactions, and medication inefficacies. Regulatory authorities, pharmaceutical companies, and healthcare professionals collaborate to collect and analyze data, ensuring compliance with safety regulations and improving animal health outcomes.
The veterinary pharmacovigilance market growth is attributed to the rising adoption of veterinary medicines, increased awareness of drug safety, and stringent regulatory requirements for adverse event reporting. The expanding global pet population and growing demand for livestock healthcare are driving the need for robust pharmacovigilance systems. Technological advancements, including artificial intelligence and cloud-based pharmacovigilance solutions, are transforming data collection and analysis, improving efficiency in monitoring drug safety. Additionally, collaborations between regulatory agencies and pharmaceutical companies are fostering better compliance and transparency in drug safety reporting. The increasing integration of digital tools and automation in pharmacovigilance processes presents veterinary pharmacovigilance market opportunities, particularly in emerging regions where veterinary healthcare infrastructure is evolving.
Veterinary Pharmacovigilance Market Report Highlights
By solution, the software segment dominated the veterinary pharmacovigilance market share in 2024. These specialized applications are designed to improve the monitoring and management of adverse drug reactions and safety data associated with veterinary pharmaceuticals
By type, the in-house segment held a larger market share. These services involve pharmaceutical companies and animal health organizations managing their pharmacovigilance activities internally, from data collection to adverse event reporting and regulatory compliance.
By region, North America holds the largest share of the veterinary pharmacovigilance market revenue, primarily due to its advanced veterinary healthcare infrastructure and stringent regulatory frameworks.
Europe represents a significant segment in the global market, driven by stringent regulatory frameworks and a well-established veterinary healthcare system.
The veterinary pharmacovigilance market comprises several active companies dedicated to ensuring the safety and efficacy of veterinary medicinal products. A few notable companies are Accenture, ArisGlobal, Azierta Contract Science Support Consulting, Biologit, Ennov, Indivirtus, Knoell, Oy Medfiles Ltd., Pharsafer Associates Limited, and Sarjen Systems Pvt. Ltd.
Polaris Market Research has segmented the veterinary pharmacovigilance market report on the basis of solution, type, product, animal type, and region:
By Solution Outlook (Revenue – USD Million, 2020–2034)
Software
Services
By Type Outlook (Revenue – USD Million, 2020–2034)
In-house
Contract Outsourcing
By Product Outlook (Revenue – USD Million, 2020–2034)
Biologics
Anti-Infective
Other Product
By Animal Type Outlook (Revenue – USD Million, 2020–2034)
Dogs
Cats
Other Animal Types
By Regional Outlook (Revenue – USD Million, 2020–2034)
North America
Veterinary pharmacovigilance refers to the systematic process of monitoring, detecting, assessing, and preventing adverse effects and other safety concerns related to veterinary medicinal products. It ensures the safe and effective use of veterinary drugs by identifying potential risks, adverse drug reactions, and medication inefficacies. Regulatory authorities, pharmaceutical companies, and healthcare professionals collaborate to collect and analyze data, ensuring compliance with safety regulations and improving animal health outcomes.
The veterinary pharmacovigilance market growth is attributed to the rising adoption of veterinary medicines, increased awareness of drug safety, and stringent regulatory requirements for adverse event reporting. The expanding global pet population and growing demand for livestock healthcare are driving the need for robust pharmacovigilance systems. Technological advancements, including artificial intelligence and cloud-based pharmacovigilance solutions, are transforming data collection and analysis, improving efficiency in monitoring drug safety. Additionally, collaborations between regulatory agencies and pharmaceutical companies are fostering better compliance and transparency in drug safety reporting. The increasing integration of digital tools and automation in pharmacovigilance processes presents veterinary pharmacovigilance market opportunities, particularly in emerging regions where veterinary healthcare infrastructure is evolving.
Veterinary Pharmacovigilance Market Report Highlights
By solution, the software segment dominated the veterinary pharmacovigilance market share in 2024. These specialized applications are designed to improve the monitoring and management of adverse drug reactions and safety data associated with veterinary pharmaceuticals
By type, the in-house segment held a larger market share. These services involve pharmaceutical companies and animal health organizations managing their pharmacovigilance activities internally, from data collection to adverse event reporting and regulatory compliance.
By region, North America holds the largest share of the veterinary pharmacovigilance market revenue, primarily due to its advanced veterinary healthcare infrastructure and stringent regulatory frameworks.
Europe represents a significant segment in the global market, driven by stringent regulatory frameworks and a well-established veterinary healthcare system.
The veterinary pharmacovigilance market comprises several active companies dedicated to ensuring the safety and efficacy of veterinary medicinal products. A few notable companies are Accenture, ArisGlobal, Azierta Contract Science Support Consulting, Biologit, Ennov, Indivirtus, Knoell, Oy Medfiles Ltd., Pharsafer Associates Limited, and Sarjen Systems Pvt. Ltd.
Polaris Market Research has segmented the veterinary pharmacovigilance market report on the basis of solution, type, product, animal type, and region:
By Solution Outlook (Revenue – USD Million, 2020–2034)
Software
Services
By Type Outlook (Revenue – USD Million, 2020–2034)
In-house
Contract Outsourcing
By Product Outlook (Revenue – USD Million, 2020–2034)
Biologics
Anti-Infective
Other Product
By Animal Type Outlook (Revenue – USD Million, 2020–2034)
Dogs
Cats
Other Animal Types
By Regional Outlook (Revenue – USD Million, 2020–2034)
North America
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
120 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Veterinary Pharmacovigilance Market Insights
- 4.1. Veterinary Pharmacovigilance Market – Market Snapshot
- 4.2. Veterinary Pharmacovigilance Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Stringent regulatory requirements
- 4.2.1.2. Increasing prevalence of adverse drug events
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of standardized reporting systems
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Veterinary Pharmacovigilance Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Veterinary Pharmacovigilance Market, by Solution
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 5.3. Software
- 5.3.1. Global Veterinary Pharmacovigilance Market, by Software, by Region, 2020–2034 (USD Million)
- 5.4. Services
- 5.4.1. Global Veterinary Pharmacovigilance Market, by Services, by Region, 2020–2034 (USD Million)
- 6. Global Veterinary Pharmacovigilance Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 6.3. In-house
- 6.3.1. Global Veterinary Pharmacovigilance Market, by In-house, by Region, 2020–2034 (USD Million)
- 6.4. Contract Outsourcing
- 6.4.1. Global Veterinary Pharmacovigilance Market, by Contract Outsourcing, by Region, 2020–2034 (USD Million)
- 7. Global Veterinary Pharmacovigilance Market, by Product
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 7.3. Biologics
- 7.3.1. Global Veterinary Pharmacovigilance Market, by Biologics, by Region, 2020–2034 (USD Million)
- 7.4. Anti-Infective
- 7.4.1. Global Veterinary Pharmacovigilance Market, by Anti-Infective, by Region, 2020–2034 (USD Million)
- 7.5. Other Product
- 7.5.1. Global Veterinary Pharmacovigilance Market, by Other Product, by Region, 2020–2034 (USD Million)
- 8. Global Veterinary Pharmacovigilance Market, by Animal Type
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 8.3. Dogs
- 8.3.1. Global Veterinary Pharmacovigilance Market, by Dogs, by Region, 2020–2034 (USD Million)
- 8.4. Cats
- 8.4.1. Global Veterinary Pharmacovigilance Market, by Cats, by Region, 2020–2034 (USD Million)
- 8.5. Other Animal Types
- 8.5.1. Global Veterinary Pharmacovigilance Market, by Other Animal Types, by Region, 2020–2034 (USD Million)
- 9. Global Veterinary Pharmacovigilance Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Veterinary Pharmacovigilance Market Assessment, By Geography, 2020–2034 (USD Million)
- 9.3. Veterinary Pharmacovigilance Market – North America
- 9.3.1. North America: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.3.2. North America: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.3.3. North America: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.3.4. North America: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.3.5. Veterinary Pharmacovigilance Market – US
- 9.3.5.1. US: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.3.5.2. US: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.3.5.3. US: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.3.5.4. US: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.3.6. Veterinary Pharmacovigilance Market – Canada
- 9.3.6.1. Canada: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.3.6.2. Canada: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.3.6.3. Canada: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.3.6.4. Canada: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.4. Veterinary Pharmacovigilance Market – Europe
- 9.4.1. Europe: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.4.2. Europe: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.4.3. Europe: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.4.4. Europe: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.4.5. Veterinary Pharmacovigilance Market – UK
- 9.4.5.1. UK: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.4.5.2. UK: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.4.5.3. UK: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.4.5.4. UK: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.4.6. Veterinary Pharmacovigilance Market – France
- 9.4.6.1. France: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.4.6.2. France: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.4.6.3. France: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.4.6.4. France: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.4.7. Veterinary Pharmacovigilance Market – Germany
- 9.4.7.1. Germany: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.4.7.2. Germany: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.4.7.3. Germany: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.4.7.4. Germany: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.4.8. Veterinary Pharmacovigilance Market – Italy
- 9.4.8.1. Italy: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.4.8.2. Italy: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.4.8.3. Italy: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.4.8.4. Italy: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.4.9. Veterinary Pharmacovigilance Market – Spain
- 9.4.9.1. Spain: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.4.9.2. Spain: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.4.9.3. Spain: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.4.9.4. Spain: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.4.10. Veterinary Pharmacovigilance Market – Netherlands
- 9.4.10.1. Netherlands: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.4.10.2. Netherlands: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.4.10.3. Netherlands: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.4.10.4. Netherlands: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.4.11. Veterinary Pharmacovigilance Market – Russia
- 9.4.11.1. Russia: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.4.11.2. Russia: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.4.11.3. Russia: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.4.11.4. Russia: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.4.12. Veterinary Pharmacovigilance Market – Rest of Europe
- 9.4.12.1. Rest of Europe: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.4.12.2. Rest of Europe: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.4.12.3. Rest of Europe: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.4.12.4. Rest of Europe: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.5. Veterinary Pharmacovigilance Market – Asia Pacific
- 9.5.1. Asia Pacific: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.5.2. Asia Pacific: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.5.3. Asia Pacific: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.5.4. Asia Pacific: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.5.5. Veterinary Pharmacovigilance Market – China
- 9.5.5.1. China: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.5.5.2. China: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.5.5.3. China: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.5.5.4. China: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.5.6. Veterinary Pharmacovigilance Market – India
- 9.5.6.1. India: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.5.6.2. India: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.5.6.3. India: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.5.6.4. India: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.5.7. Veterinary Pharmacovigilance Market – Malaysia
- 9.5.7.1. Malaysia: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.5.7.2. Malaysia: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.5.7.3. Malaysia: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.5.7.4. Malaysia: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.5.8. Veterinary Pharmacovigilance Market – Japan
- 9.5.8.1. Japan: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.5.8.2. Japan: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.5.8.3. Japan: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.5.8.4. Japan: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.5.9. Veterinary Pharmacovigilance Market – Indonesia
- 9.5.9.1. Indonesia: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.5.9.2. Indonesia: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.5.9.3. Indonesia: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.5.9.4. Indonesia: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.5.10. Veterinary Pharmacovigilance Market – South Korea
- 9.5.10.1. South Korea: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.5.10.2. South Korea: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.5.10.3. South Korea: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.5.10.4. South Korea: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.5.11. Veterinary Pharmacovigilance Market – Australia
- 9.5.11.1. Australia: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.5.11.2. Australia: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.5.11.3. Australia: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.5.11.4. Australia: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.5.12. Veterinary Pharmacovigilance Market – Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.5.12.2. Rest of Asia Pacific: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.5.12.3. Rest of Asia Pacific: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.5.12.4. Rest of Asia Pacific: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.6. Veterinary Pharmacovigilance Market – Middle East & Africa
- 9.6.1. Middle East & Africa: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.6.2. Middle East & Africa: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.6.3. Middle East & Africa: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.6.4. Middle East & Africa: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.6.5. Veterinary Pharmacovigilance Market – Saudi Arabia
- 9.6.5.1. Saudi Arabia: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.6.5.2. Saudi Arabia: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.6.5.3. Saudi Arabia: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.6.5.4. Saudi Arabia: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.6.6. Veterinary Pharmacovigilance Market – UAE
- 9.6.6.1. UAE: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.6.6.2. UAE: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.6.6.3. UAE: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.6.6.4. UAE: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.6.7. Veterinary Pharmacovigilance Market – Israel
- 9.6.7.1. Israel: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.6.7.2. Israel: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.6.7.3. Israel: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.6.7.4. Israel: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.6.8. Veterinary Pharmacovigilance Market – South Africa
- 9.6.8.1. South Africa: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.6.8.2. South Africa: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.6.8.3. South Africa: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.6.8.4. South Africa: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.6.9. Veterinary Pharmacovigilance Market – Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.6.9.2. Rest of Middle East & Africa: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.6.9.3. Rest of Middle East & Africa: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.6.9.4. Rest of Middle East & Africa: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.7. Veterinary Pharmacovigilance Market – Latin America
- 9.7.1. Latin America: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.7.2. Latin America: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.7.3. Latin America: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.7.4. Latin America: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.7.5. Veterinary Pharmacovigilance Market – Mexico
- 9.7.5.1. Mexico: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.7.5.2. Mexico: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.7.5.3. Mexico: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.7.5.4. Mexico: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.7.6. Veterinary Pharmacovigilance Market – Brazil
- 9.7.6.1. Brazil: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.7.6.2. Brazil: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.7.6.3. Brazil: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.7.6.4. Brazil: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.7.7. Veterinary Pharmacovigilance Market – Argentina
- 9.7.7.1. Argentina: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.7.7.2. Argentina: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.7.7.3. Argentina: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.7.7.4. Argentina: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 9.7.8. Veterinary Pharmacovigilance Market – Rest of Latin America
- 9.7.8.1. Rest of Latin America: Veterinary Pharmacovigilance Market, by Solution, 2020–2034 (USD Million)
- 9.7.8.2. Rest of Latin America: Veterinary Pharmacovigilance Market, by Type, 2020–2034 (USD Million)
- 9.7.8.3. Rest of Latin America: Veterinary Pharmacovigilance Market, by Product, 2020–2034 (USD Million)
- 9.7.8.4. Rest of Latin America: Veterinary Pharmacovigilance Market, by Animal Type, 2020–2034 (USD Million)
- 10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 11.1. Accenture PLC
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Azierta Life Sciences & Health Consulting Firm S.L.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Biologit
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Bimeda Holdings plc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Ceva Santé Animale
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Elanco Animal Health Incorporated
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Ennov SAS
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Indivirtus Group (Indivirtus Healthcare Services)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Knoell Germany GmbH
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Norbrook Laboratories Limited
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
